Navigation Links
'Leave It To Beaver' Star Visits Kannapolis to Promote Prescription Assistance
Date:10/30/2009

WASHINGTON, Oct. 30 /PRNewswire-USNewswire/ -- The Salisbury Post reported that sitcom star Jerry Mathers visited Kannapolis to promote prescription drug assistance for poor and uninsured patients.

Mathers, 61, played Theodore "The Beaver" Cleaver on the hit 1950s TV show "Leave It To Beaver." After retirement, his life continued to be "typically American." Mathers developed type 2 diabetes after gaining sixty 60 pounds.

"My doctor told me I would be dead in three to five years unless I treated my diabetes," said Mathers.

He appeared in Kannapolis on behalf of the Partnership for Prescription Assistance (PPA), a program sponsored by America's pharmaceutical research companies. The program helps enroll poor and uninsured patients in existing prescription assistance programs, so they can get the medications they need. PPA doesn't provide medications, but acts as a clearinghouse for 475 patient assistance programs that offer inexpensive or free medicines.

"I have health insurance," Mathers said. "But I know how expensive a chronic disease can be for people without it."

The Partnership for Prescription Assistance "Help is Here Express" bus spent three hours at the Cabarrus Health Alliance last Wednesday. Mathers signed about 150 autographs.

Cabarrus Health Alliance employee Ashley Goodman was thrilled to meet Mathers.

"I love your show," Goodman said. "I think it's great that they have a celebrity to draw people. It's exciting."

Read the full article on the Salisbury Post website. For more information on the Partnership for Prescription Assistance, visit www.pparx.org

SOURCE Pharmaceutical Research and Manufacturers of America


'/>"/>
SOURCE Pharmaceutical Research and Manufacturers of America
Copyright©2009 PR Newswire.
All rights reserved

Related medicine technology :

1. New Survey Suggests Cultural Ambivalence to Allergies Leaves Many Suffering Needlessly
2. The Anatomy of Clinical Trials: Greys Season Finale Leaves Public in the Dark About the Myths and Realities
3. Starting Flu Vaccination in August Could Help Protect Nearly 11 Million More Children During Scheduled Doctors Visits
4. VIA Pharmaceuticals Completes Patient Visits in Phase 2 Carotid Endarterectomy (CEA) Trial
5. VIA Pharmaceuticals Completes Patient Visits in Phase 2 Acute Coronary Syndrome (ACS) Trial
6. New Study Suggests Cholesterol-Lowering Statins Reduce Severe Asthma Attacks that Result in Hospitalizations and Emergency Room Visits
7. Pivotal Data Show Bronchial Thermoplasty Can Improve Quality of Life and Reduce Asthma Attacks and Emergency Room Visits for Adults with Severe Asthma
8. National Stem Cell Holding, Inc. Discovers Non-Embryonic Biomaterials that Promote Tissue Repair
9. Diabetes Research Institute Invention Promotes Growth of Stem Cells into Insulin-Producing Cells
10. Vical Promotes Melanoma Awareness Month With Allovectin-7(R) Video Report
11. AST on Capitol Hill to Promote Transplant Drug Extension Provision With Senate as Part of Health Care Reform
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/23/2017)... 23, 2017  Cornerstone Pharmaceuticals, Inc., a ... milestone today.  Following successful End-of-Phase I (EOP1) ... and Drug Administration (FDA), the Company has ... path forward to conduct pivotal trials of ... acute myeloid leukemia (AML) and pancreatic cancer. ...
(Date:3/23/2017)... March 23, 2017 Piramal ... Limited, anuncia el nombramiento de Stuart E. ... plataforma de servicios integrados completa para su base ... cargo clave en el crecimiento y ejecución de ... responsable de impulsar todas las actividades de desarrollo ...
(Date:3/23/2017)... Merrimack Pharmaceuticals, Inc. (NASDAQ: MACK ) ... a Phase 1 study of MM-310 in solid tumors. ... novel taxane and targets the EphA2 receptor, a protein ... major tumor types, including prostate, ovarian, bladder, gastric, pancreatic ... study is an important step in evaluating MM-310,s safety ...
Breaking Medicine Technology:
(Date:3/23/2017)... ... March 23, 2017 , ... The ... from the NCQA. The accreditation covers StayWell’s asthma, coronary artery disease, congestive heart ... granted to organizations that have excellent programs for the delivery and improvement of ...
(Date:3/23/2017)... ... March 23, 2017 , ... March 23, 2017 - ... to easily reprint customer invoices, bills, statements and other correspondence when they have ... needed to retrieve and print the documents and batch them for efficient handling. ...
(Date:3/23/2017)... OR (PRWEB) , ... March 23, 2017 , ... Sharon ... Water, Global Climate Change and Your Health on VoiceAmerica, recently talked on her program ... she also used the occasion to remind listeners of an important distinction. World Water ...
(Date:3/23/2017)... ... March 23, 2017 , ... Corra Group is ... competitive pricing. Verisys through its FACIS and other services maintains the ... actions. , “We are delighted to be able to offer these various products ...
(Date:3/23/2017)... ... March 23, 2017 , ... ... New MEDDEV 2.7/1 Rev. 4 Guidance, **An FDAnews Webinar**, April 4, 2017 ... will the new EU MDR language change the way manufacturers approach CERs? ...
Breaking Medicine News(10 mins):